Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
March 05 2024 - 4:05PM
Transactions in Zealand Pharma shares and/or related securities by
persons discharging managerial responsibilities and/or their
closely associated persons
Company announcement – No. 12 / 2024
Transactions in Zealand Pharma shares and/or related
securities by persons discharging managerial responsibilities
and/or their closely associated persons
Copenhagen, Denmark, March 5, 2024 – Zealand Pharma A/S
(“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a
Copenhagen-based biotechnology company focused on the discovery and
development of innovative peptide-based medicines, has received
information on transactions in Zealand's shares or related
securities conducted by persons discharging managerial
responsibilities and/or their closely associated persons and hereby
publishes the information on such transactions.
Please see the attached file(s).
# # #
About Zealand Pharma A/SZealand Pharma A/S
(Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on
the discovery and development of peptide-based medicines. More than
10 drug candidates invented by Zealand have advanced into clinical
development, of which two have reached the market and three
candidates are in late-stage development. The company has
development partnerships with a number of pharma companies as well
as commercial partnerships for its marketed products.
Zealand was founded in 1998 and is headquartered in Copenhagen,
Denmark, with a presence in the U.S. For more information about
Zealand’s business and activities, please
visit www.zealandpharma.com.
Contact:
Anna Krassowska, PhD Vice President, Investor Relations &
Corporate Communications Zealand Pharma Email:
ank@zealandpharma.com |
- Zealand Pharma - Transactions - 20240305
Zealand Pharma AS (TG:22Z)
Historical Stock Chart
From Aug 2024 to Sep 2024
Zealand Pharma AS (TG:22Z)
Historical Stock Chart
From Sep 2023 to Sep 2024